Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - alfuzosin hydrochloride 5 mg - prolonged-release tablet - 5 mg - alfuzosin hydrochloride 5 mg - alfuzosin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - alfuzosin hydrochloride 10 mg - prolonged-release tablet - 10 mg - alfuzosin hydrochloride 10 mg - alfuzosin

Singapore - English - HSA (Health Sciences Authority)

pharmaforte singapore pte ltd - alfuzosin hydrochloride - tablet, extended release - alfuzosin hydrochloride 10mg

Israel - English - Ministry of Health

sanofi israel ltd - alfuzosin hydrochloride - tablets sustained release - alfuzosin hydrochloride 5 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason

Israel - English - Ministry of Health

sanofi israel ltd - alfuzosin hydrochloride - tablets prolonged release - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.

Canada - English - Health Canada

sandoz canada incorporated - alfuzosin hydrochloride - tablet (extended-release) - 10mg - alfuzosin hydrochloride 10mg - selective alfa-1-adrenergic blocking agents

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - alfuzosin hydrochloride - prolonged-release tablet - alfuzosin hydrochloride 10 mg - urologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - alfuzosin hydrochloride, quantity: 10 mg - tablet, modified release - excipient ingredients: magnesium stearate; ethylcellulose; microcrystalline cellulose; iron oxide yellow; silicon dioxide; mannitol; hypromellose; hydrogenated castor oil; povidone - indicated for the treatment of the functional symptoms of benign prostatic hyperplasia.

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - alfuzosin hydrochloride - tablet prolonged release - 10 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - alfuzosin hydrochloride - prolonged-release tablet - 10 milligram(s) - alpha-adrenoreceptor antagonists; alfuzosin